uniQure to Present at the RBC Capital Markets 2016 Global Healthcare Conference
February 15 2016 - 5:00AM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy,
announced today that Dan Soland, Chief Executive Officer, will
present at the RBC Capital Markets 2016 Global Healthcare
Conference on February 24, 2016 at 2:05 p.m. EST / 20:05 pm CET.
The conference is being held February 23 - 24, 2016 at The Palace
Hotel in New York City.
The webcast, including a slide presentation, can be accessed
through the following link:
http://www.veracast.com/webcasts/rbc/healthcare2016/26211430508.cfm
or by accessing the link displayed in the "Events" section on the
"Media" page of the uniQure website at:
http://www.uniqure.com/news/calendar-of-events/. The replay of the
webcast will be available one hour after the conclusion of the live
event and archived on the uniQure website for at least 30 days
following the webcast.
About uniQure
uniQure is delivering on the promise of gene therapy – single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with CNS, liver/metabolic and cardiovascular diseases.
www.uniQure.com
CONTACT: uniQure:
Eva Mulder
Direct : +31 20 240 6103
Main: +31 20 240 6000
e.mulder@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024